Phosphorylated Akt had a significantly higher median expression level in AML with recurrent genetic abnormalities compared to the others (N = 29, Independent Samples t-test p = 0.044), in concordance with this, only one patient had low phospho-Akt level in this subgroup (N = 29/1 Pearson Chi-Square test p = 0.026). This evidence concerns the gene AKT1 and acute myeloid leukemia.